<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/64BC5E73-972F-41E1-A12C-D97DC9BDFB93"><gtr:id>64BC5E73-972F-41E1-A12C-D97DC9BDFB93</gtr:id><gtr:name>MRC Clinical Sciences Centre</gtr:name><gtr:address><gtr:line1>Faculty of Medicine Imperial College</gtr:line1><gtr:line2>London Hammersmith Campus</gtr:line2><gtr:line3>Du Cane Road</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>W12 0NN</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/64BC5E73-972F-41E1-A12C-D97DC9BDFB93"><gtr:id>64BC5E73-972F-41E1-A12C-D97DC9BDFB93</gtr:id><gtr:name>MRC Clinical Sciences Centre</gtr:name><gtr:address><gtr:line1>Faculty of Medicine Imperial College</gtr:line1><gtr:line2>London Hammersmith Campus</gtr:line2><gtr:line3>Du Cane Road</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>W12 0NN</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/C72453A9-37BA-4272-9677-46545329EAB0"><gtr:id>C72453A9-37BA-4272-9677-46545329EAB0</gtr:id><gtr:firstName>Susumu</gtr:firstName><gtr:surname>Hirabayashi</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_UP_1102%2F16"><gtr:id>91FA7426-545C-454B-8220-7B7B0DF861A7</gtr:id><gtr:title>Metabolism and Cell Growth</gtr:title><gtr:status>Active</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_UP_1102/16</gtr:grantReference><gtr:abstractText>The fruit fly Drosophila melanogaster has only recently been used as a model to study human diseases including metabolic disorders and cancer, but has started to provide important insights into the biological basis and therapeutic targets of various human diseases. The ability to perform genetic screens provides a powerful systemic approach to identify new and unexpected molecular links in a whole-animal setting. 
 Accumulating epidemiological evidence indicates that obesity is a risk factor for several types of cancers. Conversely, cancer progression induces cachexia, a complex metabolic syndrome associated with progressive body weight loss. However, a biological basis for the associations between whole-animal metabolism and cancer remain incompletely understood. By using Drosophila melanogaster, our research aims to understand the biological connections between whole-body metabolism and cancer.
 Considering the pandemic increase in obese populations worldwide, understanding of how obesity affects cancer is important for developing preventative interventions and treatments strategies that can benefit public health. Cancer-induced cachexia can profoundly influence the quality of life for cancer patients. Our research aims to unravel the biological mechanisms involved in cancer-induced metabolic syndromes and to develop therapeutic strategies to improve the quality of life of cancer patients.</gtr:abstractText><gtr:technicalSummary>The prevalence of obesity is increasing globally. Accumulating epidemiological evidence implies that obesity?associated with insulin resistance?is a risk factor for several types of cancers. However, a biological basis for the associations between whole-animal metabolism and cancer remain incompletely understood. 
 Using Drosophila, I have developed a model system to study the link between obesity and cancer (Hirabayashi et al. 2013, Cell 154, 664). Feeding Drosophila a high-sucrose diet was previously demonstrated to promote metabolic defects including accumulation of fat, hyperglycemia, increased insulin levels (hyperinsulinemia), insulin resistance, and heart defects, indicating that the simple feeding model recapitulated many of the metabolic features of mammalian obesity. A high-sucrose diet also leads to a striking enhancement of tumour progression in a Ras/Src co-activated Drosophila tumour model. Diet-induced tumour growth has consequences on animal viability, evidenced by the death of most larvae prior to pupariation. This synergistic, diet-plus-cancer dependent mortality is an ideal phenotype for genetic screens designed to identify regulators of obesity-dependent tumourigenesis. I will further utilize this Drosophila diet-enhanced tumour model as useful whole-animal systems to better understand the mechanistic links between diet-induced metabolic defects and tumour progression. 
 Conversely, cancer progression induces metabolic changes including cancer-associated cachexia, a wasting syndrome of progressive muscle and adipose tissue loss. Cancer-induced metabolic changes can profoundly influence treatment efficacy and the quality of life for cancer patients. However, the biological mechanism for the cancer-induced metabolic changes are not well understood. Animals with diet-enhanced Ras/Src-tumours possess less fat body (i.e., Drosophila adipose tissue). This metabolic feature recapitulated cachexia-like adipose tissue wasting of cancer patients and is suitable for addressing a complementary question of how tumours affect whole-animal metabolism. 
 Overall, our research goal is to discover and elucidate the biological mechanisms and therapeutic targets involved in the interactions between metabolism and tumour progression in a whole-animal context.</gtr:technicalSummary><gtr:fund><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2014-11-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>652548</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>880DBE06-9AFD-4650-800E-CC07BF03F1E7</gtr:id><gtr:title>The interplay between obesity and cancer: a fly view.</gtr:title><gtr:parentPublicationTitle>Disease models &amp; mechanisms</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/475e889e44f96d814ec940175c2d8e06"><gtr:id>475e889e44f96d814ec940175c2d8e06</gtr:id><gtr:otherNames>Hirabayashi S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1754-8403</gtr:issn><gtr:outcomeId>589dedf01d9d51.32237705</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9E7A0859-A757-4E4E-982C-D819617E1FB0</gtr:id><gtr:title>Salt-inducible kinases mediate nutrient-sensing to link dietary sugar and tumorigenesis in Drosophila.</gtr:title><gtr:parentPublicationTitle>eLife</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/475e889e44f96d814ec940175c2d8e06"><gtr:id>475e889e44f96d814ec940175c2d8e06</gtr:id><gtr:otherNames>Hirabayashi S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2050-084X</gtr:issn><gtr:outcomeId>5655e65754b060.74506964</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_UP_1102/16</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>7C58A707-1BF6-4573-A44F-30B271C80813</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Cancer</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>